查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421745

疫苗合約製造市場、份額、規模、趨勢、行業分析報告：按疫苗類型、應用、工藝、地區和細分市場預測，2023-2032

Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type ; By Application; By Process; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球疫苗合約製造市場預計將達到131.6億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

製藥和生物製藥公司正在策略上優先考慮核心競爭力，以在日益激烈的價格競爭中生存。 因此，合約製造的趨勢日益明顯。

然而，疫苗生產給製造商帶來了複雜的挑戰，因為他們努力確保安全性、有效性和一致性。 疫苗合約製造市場由多種服務驅動，包括製造流程、製造設施建立和運作、細胞系開發、發酵、製程改進、分析表徵等。 總的來說，這些服務在推動全球市場的顯著成長方面發揮關鍵作用。

疫苗接種對於促進人畜健康有重要作用。 它不僅減少了對抗生素的依賴，而且對多種疾病起到了強有力的威懾作用。 現在人們認識到疫苗接種具有多種好處，例如預防嚴重疾病和傳染病，並且疫苗接種工作和計劃正在廣泛倡導。 這導致大型製藥公司意識到製造需要大量資金，因此選擇在疫苗生產領域外包。

然而，資源匱乏國家缺乏疫苗生產設備和熟練勞動力，這是推動全球疫苗合約製造市場擴大的主要因素。 此外，EB66和GPEx等先進表達系統的引入以及創新的細胞培養基平台也極大地支持了市場的成長。 此外，各國COVID-19病例的快速增加促使疫苗開發公司與合約製造組織(CMO)簽訂外包協議，為市場發展創造了積極的軌跡。

疫苗合約製造市場報告亮點

由於效率高，滅活疫苗產業預計在預測期內複合年增長率最快。

2022年，獸醫部門在收入中佔據很大份額，這主要是由於在獸用疫苗生產中越來越多地使用CMO。

2022年，由於技術進步和創新，下游產業佔據最大的市場份額。

2022年，由於技術的指數級增長和研發投資的增加，北美地區佔據了最大的市場份額。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第 4 章全球疫苗合約製造市場洞察

  • 疫苗合約製造市場 - 流程快照
  • 疫苗合約製造市場動態
    • 推動者和機會
      • 疫苗需求的增加預計將刺激對該產品的需求
      • 生物製藥領域的進展
    • 抑制因素和挑戰
      • 複雜的監理環境
  • PESTEL 分析
  • 疫苗合約製造市場的製程趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球疫苗合約製造市場(以疫苗類型)

  • 主要調查結果
  • 簡介
  • 滅活□□疫苗
  • DNA疫苗
  • 減毒疫苗
  • 類毒素疫苗
  • 次單位疫苗

第6章全球疫苗合約製造市場，依應用劃分

  • 主要調查結果
  • 簡介
  • 人類
  • 動物

第7章全球疫苗合約製造市場(依流程)

  • 主要調查結果
  • 簡介
  • 上游
  • 下游

第8章區域性全球疫苗合約製造市場

  • 主要調查結果
  • 簡介
    • 2019-2032 年疫苗合約製造市場評估(按地區)
  • 疫苗合約製造市場 - 北美
    • 北美：2019-2032 年疫苗合約製造市場(以疫苗類型)
    • 北美：疫苗合約製造市場(依流程)，2019-2032 年
    • 北美：疫苗合約製造市場，按應用劃分，2019-2032 年
    • 疫苗合約製造市場 - 美國
    • 疫苗合約製造市場 - 加拿大
  • 疫苗合約製造市場 - 歐洲
    • 歐洲：疫苗合約製造市場(以疫苗類型)，2019-2032 年
    • 歐洲：疫苗合約製造市場(依流程)，2019-2032 年
    • 歐洲：疫苗合約製造市場，依應用劃分，2019-2032 年
    • 疫苗合約製造市場 - 英國
    • 疫苗合約製造市場 - 法國
    • 疫苗合約製造市場 - 德國
    • 疫苗合約製造市場 - 義大利
    • 疫苗合約製造市場 - 西班牙
    • 疫苗合約製造市場 - 荷蘭
    • 疫苗合約製造市場 - 俄羅斯
  • 疫苗合約製造市場 - 亞太地區
    • 亞太地區：2019-2032 年疫苗合約製造市場(依疫苗類型)
    • 亞太地區：疫苗合約製造市場(依流程)，2019-2032 年
    • 亞太地區：疫苗合約製造市場，按應用劃分，2019-2032 年
    • 疫苗合約製造市場 - 中國
    • 疫苗合約製造市場 - 印度
    • 疫苗合約製造市場 - 馬來西亞
    • 疫苗合約製造市場 - 日本
    • 疫苗合約製造市場 - 印尼
    • 疫苗合約製造市場 - 韓國
  • 疫苗合約製造市場 - 中東/非洲
    • 中東和非洲：2019-2032 年疫苗合約製造市場(按疫苗類型)
    • 中東和非洲：疫苗合約製造市場(按流程)，2019-2032 年
    • 中東和非洲：疫苗合約製造市場，按應用劃分，2019-2032 年
    • 疫苗合約製造市場 - 沙烏地阿拉伯
    • 疫苗合約製造市場 - 阿拉伯聯合大公國
    • 疫苗合約製造市場 - 以色列
    • 疫苗合約製造市場 - 南非
  • 疫苗合約製造市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年疫苗合約製造市場(依疫苗類型)
    • 拉丁美洲：疫苗合約製造市場(按流程)，2019-2032 年
    • 拉丁美洲：疫苗合約製造市場，按應用劃分，2019-2032 年
    • 疫苗合約製造市場 - 墨西哥
    • 疫苗合約製造市場 - 巴西
    • 疫苗合約製造市場 - 阿根廷

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • AGC Biologics
  • Catalent, Inc.
  • Charles River Laboratories
  • Emergent BioSolutions
  • Fujifilm Diosynth Biotechnologies
  • IDT Biologika GmbH
  • KBI Biopharma
  • Lonza Group
  • Merck KGaA
  • Recipharm AB
  • Richter-Helm BioLogics GmbH & Co. KG
  • Seqirus(CSL Limited)
  • WuXi Biologics
  • Samsung Biologics
Product Code: PM4069

The global vaccine contract manufacturing market size is expected to reach USD 13.16 billion by 2032, according to a new study by Polaris Market Research. The report "Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type (Inactivated Vaccine, DNA Vaccines, Attenuated Vaccine, Toxoid Vaccines, Subunit Vaccines); By Application; By Process; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical and biopharmaceutical companies are strategically prioritizing their core competencies to navigate the escalating price pressures. Consequently, there is a growing inclination towards contract manufacturing.

However, vaccine production presents a complex challenge for manufacturers as they strive to guarantee safety, effectiveness, and consistency. The vaccine contract manufacturing market is driven by a diverse range of services encompassing production processes, the establishment and operation of manufacturing facilities, cell line development, fermentation, process refinement, and analytical characterization. These services collectively play a pivotal role in driving the market's substantial growth on a worldwide level.

Vaccination plays an important role in enhancing both human and veterinary health. It not only diminishes reliance on antibiotics but also serves as a potent deterrent against various diseases. The escalating recognition of its manifold advantages, which include safeguarding against severe illnesses and infectious conditions, is fueling the call for widespread immunization initiatives and inoculation programs. In tandem with this, the cognizance of the substantial capital outlay needed for production has prompted major pharmaceutical entities to opt for outsourcing in the realm of vaccine manufacturing.

However, in low-resource countries, the shortage of equipment and proficient labor for vaccine production is a significant factor driving the expansion of the global vaccine contract manufacturing market. Additionally, the introduction of advanced expression systems such as EB66 and GPEx, along with innovative cell culture media platforms, is providing substantial support for market growth. Furthermore, the surging instances of COVID-19 in various nations have prompted vaccine developers to engage in outsourcing agreements with Contract Manufacturing Organizations (CMOs), fostering a positive trajectory for market advancement.

Vaccine Contract Manufacturing Market Report Highlights

The Inactivated Vaccine segment is expected to witness the fastest CAGR during the forecast period on account of better efficiency.

The veterinary segment held a significant share in revenue share in 2022, which is mainly driven by increased utilization of CMOs in the production of animal vaccinations.

In 2022, the downstream segment held the largest market share due to technological advancements and innovation.

In 2022, the North American region held the largest market share, owing to exponential growth in technology and rising R&D investments.

The global key market players include: Fujifilm Diosynth Biotechnologies, IDT Biologika GmbH, KBI Biopharma, Lonza Group, Merck KGaA, and more.

Polaris Market Research has segmented the vaccine contract manufacturing market report based on vaccine type, application, process, and region:

Vaccine Contract Manufacturing, Vaccine Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inactivated Vaccine
  • DNA Vaccines
  • Attenuated Vaccine
  • Toxoid Vaccines
  • Subunit Vaccines

Vaccine Contract Manufacturing, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Human
  • Veterinary

Vaccine Contract Manufacturing, Process Outlook (Revenue - USD Billion, 2019 - 2032)

  • Upstream
  • Downstream

Vaccine Contract Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Vaccine Contract Manufacturing Market Insights

  • 4.1. Vaccine Contract Manufacturing Market - Process Snapshot
  • 4.2. Vaccine Contract Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased demand for vaccines is projected to spur the product demand
      • 4.2.1.2. Biopharmaceutical Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex Regulatory Environment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Vaccine Contract Manufacturing Market Process Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Vaccine Contract Manufacturing Market, by Vaccine Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • 5.3. Inactivated Vaccine
    • 5.3.1. Global Vaccine Contract Manufacturing Market, by Inactivated Vaccine, by Region, 2019-2032 (USD Billion)
  • 5.4. DNA Vaccines
    • 5.4.1. Global Vaccine Contract Manufacturing Market, by DNA Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.5. Attenuated Vaccine
    • 5.5.1. Global Vaccine Contract Manufacturing Market, by Attenuated Vaccine, by Region, 2019-2032 (USD Billion)
  • 5.6. Toxoid Vaccines
    • 5.6.1. Global Vaccine Contract Manufacturing Market, by Toxoid Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.7. Subunit Vaccines
    • 5.7.1. Global Vaccine Contract Manufacturing Market, by Subunit Vaccines, by Region, 2019-2032 (USD Billion)

6. Global Vaccine Contract Manufacturing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Human
    • 6.3.1. Global Vaccine Contract Manufacturing Market, by Human, by Region, 2019-2032 (USD Billion)
  • 6.4. Veterinary
    • 6.4.1. Global Vaccine Contract Manufacturing Market, by Veterinary, by Region, 2019-2032 (USD Billion)

7. Global Vaccine Contract Manufacturing Market, by Process

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • 7.3. Upstream
    • 7.3.1. Global Vaccine Contract Manufacturing Market, by Upstream, By Region, 2019-2032 (USD Billion)
  • 7.4. Downstream
    • 7.4.1. Global Vaccine Contract Manufacturing Market, by Downstream, By Region, 2019-2032 (USD Billion)

8. Global Vaccine Contract Manufacturing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Vaccine Contract Manufacturing Market - North America
    • 8.3.1. North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.3.3. North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Vaccine Contract Manufacturing Market - U.S.
      • 8.3.4.1. U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Vaccine Contract Manufacturing Market - Canada
      • 8.3.5.1. Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Vaccine Contract Manufacturing Market - Europe
    • 8.4.1. Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Vaccine Contract Manufacturing Market - UK
      • 8.4.4.1. UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Vaccine Contract Manufacturing Market - France
      • 8.4.5.1. France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Vaccine Contract Manufacturing Market - Germany
      • 8.4.6.1. Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Vaccine Contract Manufacturing Market - Italy
      • 8.4.7.1. Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Vaccine Contract Manufacturing Market - Spain
      • 8.4.8.1. Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Vaccine Contract Manufacturing Market - Netherlands
      • 8.4.9.1. Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Vaccine Contract Manufacturing Market - Russia
      • 8.4.10.1. Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Vaccine Contract Manufacturing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Vaccine Contract Manufacturing Market - China
      • 8.5.4.1. China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Vaccine Contract Manufacturing Market - India
      • 8.5.5.1. India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Vaccine Contract Manufacturing Market - Malaysia
      • 8.5.6.1. Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Vaccine Contract Manufacturing Market - Japan
      • 8.5.7.1. Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Vaccine Contract Manufacturing Market - Indonesia
      • 8.5.8.1. Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Vaccine Contract Manufacturing Market - South Korea
      • 8.5.9.1. South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Vaccine Contract Manufacturing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Vaccine Contract Manufacturing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Vaccine Contract Manufacturing Market - UAE
      • 8.6.5.1. UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Vaccine Contract Manufacturing Market - Israel
      • 8.6.6.1. Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Vaccine Contract Manufacturing Market - South Africa
      • 8.6.7.1. South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Vaccine Contract Manufacturing Market - Latin America
    • 8.7.1. Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Vaccine Contract Manufacturing Market - Mexico
      • 8.7.4.1. Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Vaccine Contract Manufacturing Market - Brazil
      • 8.7.5.1. Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Vaccine Contract Manufacturing Market - Argentina
      • 8.7.6.1. Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AGC Biologics
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Catalent, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Charles River Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Emergent BioSolutions
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fujifilm Diosynth Biotechnologies
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. IDT Biologika GmbH
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. KBI Biopharma
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lonza Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck KGaA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Recipharm AB
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Richter-Helm BioLogics GmbH & Co. KG
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Seqirus (CSL Limited)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. WuXi Biologics
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Samsung Biologics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables

  • Table 1 Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 2 Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 4 Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 6 North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 8 U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 11 Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 14 Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 17 UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 18 UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 20 France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 21 France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 23 Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 26 Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 29 Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 35 Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 41 China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 42 China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 44 India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 45 India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 50 Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 56 South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 65 UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 68 Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 71 South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 74 Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 77 Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 80 Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 83 Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Vaccine Contract Manufacturing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Vaccine Contract Manufacturing Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Vaccine Type
  • Figure 9. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Process
  • Figure 11. Global Vaccine Contract Manufacturing Market, by Process, 2022 & 2032 (USD Billion)
  • Figure 12. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Vaccine Contract Manufacturing Market